脉血康治疗偏头痛的临床观察

Clinical Observation on Migraine Treated by Maixuekang

目的:探讨分析使用脉血康对偏头痛治疗的临床效果。方法:选择于2016年8月至2018年4月间郑州中医骨伤病医院接收的偏头痛患者86例,随机分组治疗,每组43例,对照组患者给予氟桂利嗪治疗,观察组患者则实施脉血康对患者治疗,比较两种方法在临床上的应用效果。结果:观察组患者治疗总有效率比对照组高,差异具有统计学意义(P<0.05);治疗前两组的血清总胆固醇(TC)、低密度脂蛋白(LDL),差异无统计学意义(P> 0.05),治疗后观察组患者的TC、LDL水平均较对照组更低,差异具有统计学意义(P <0.05)。结论:使用脉血康对偏头痛疾病治疗,可改善血脂水平、提高治疗效果。

Objective To investigate the clinical effect of Maixuekang on migraine. Methods 86 migraine patients received in our hospital from August 2016 to April 2018 were randomly divided into two groups. The control group was treated with flunarizine, while the research group was treated with Maixuekang. The clinical effects of the two methods were compared. Results The total effective rate of the observation group was higher than that of the control group, and the difference was statistically significant(P < 0.05). There were no significant differences in TC(serum total cholesterol) and LDL(low-density lipoprotein) between the two groups before treatment(P > 0.05). After treatment, the TC and LDL levels in the observation group were lower than those in the control group, and the difference was statistically significant(P < 0.05). Conclusion Maixuekang can improve blood lipid level and therapeutic effect in the treatment of migraine, which is worthy of popularization and application.